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Abstract   
 
Objective Haemodialysis patients are at risk of serious health complications, yet treatment 
non-adherence remains high. Warnings about health-risks associated with non-adherence may 
trigger defensive reactions. We studied whether an intervention based on self-affirmation 
theory reduced resistance to health-risk information and improved fluid treatment adherence.  
 
Design In a cluster randomised controlled trial, ninety-one patients either self-affirmed or 
completed a matched-control task before reading about the health-risks associated with 
inadequate fluid control. 
 
Outcome measures Patients’ perceptions of the health-risk information, intention and self-
efficacy to control fluid, were assessed immediately after presentation of health-risk 
information. Interdialytic-weight-gain (IDWG), excess fluid removed during hemodialysis, is 
a clinical measure of fluid treatment adherence. IDWG data were collected up to 12 months 
post intervention. 
 
Results Self-affirmed patients had significantly reduced IDWG levels over 12 months.  
However, contrary to predictions derived from self-affirmation theory, self-affirmed 
participants and controls did not differ in their evaluation of the health-risk information, 
intention to control fluid or self-efficacy.  
 
Conclusion A low-cost, high-reach health intervention based on self-affirmation theory was 
shown to reduce IDWG over a 12-month period but the mechanism by which this apparent 
behaviour change occurred is uncertain. Further work is still required to identify mediators of 
the observed effects. 
 
 
Keywords 
Self-affirmation 
Behaviour change 
Dialysis 
Adherence 
Interdialytic-weight-gain 
Fluid control 
Introduction 
Patients with end stage kidney disease (ESKD) are not able to excrete sufficient or in some 
cases any urine. Dialysis removes excess fluid but there are limits to how much fluid can be 
safely removed during a single dialysis session. ESKD patients receiving haemodialysis are 
required to restrict their fluid and salt intake as inadequate fluid control is associated with poor 
short term (e.g. hypertension, painful cramps during dialysis and extended dialysis sessions) 
and long term health outcomes (e.g. pulmonary oedema, cardiovascular risk and increased 
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mortality) see (Davenport, 2006; Denhaerynck et al., 2007). It is recommended that patients 
drink no more than 500mls of liquid plus an amount equivalent to estimated urine output, per 
day. To prevent increased fluid gains, patients should be attending for dialysis sessions with 
approximately 1-2 kilograms of interdialytic weight gain (IDWG). The weight gained between 
dialysis sessions (IDWG) indicates the amount of the excess fluid that needs to be removed in 
the treatment session, with greater weight gains indicating problematic fluid control. Although 
related to body size and residual renal function, IDWG serves to be the most reliable objective 
marker of fluid adherence. Studies of fluid adherence indicate that, perhaps not surprisingly, 
many patients find this particularly challenging to manage and often commence dialysis with 
significantly higher IDWGs than clinically desired. Estimates of fluid treatment control non-
adherence vary widely (Clark, Farrington, & Chilcot, 2014), between 10-60% when using 
IDWG as a proxy measure of adherence, and, 30-74% based on patient self-report 
(Denhaerynck et al., 2007).     
 
Patients are regularly informed and reminded about their recommended treatment in routine 
care, particularly fluid control, since patients are weighed before and after every dialysis 
session. However, merely educating patients about the risk of poor treatment control is not 
always sufficient to change behaviour (Barnett, Li Yoong, Pinikahana, & Si‐Yen, 2008; 
Haynes, 1999). For patients who consistently fail to keep within recommended fluid levels, the 
receipt of regular feedback that their behaviour is putting their health at risk, is potentially 
threatening. Such perceptions of threat may lead to defensive responses (Cohen & Sherman, 
2014).   Self-affirmation theory (Steele, 1988) predicts that people are likely to ignore or reject 
health-risk information when the information conflicts with their own behaviour because it 
threatens their self-integrity (the sense that one is a good person),. Thus, patients who do not 
adhere to their recommended fluid intake are more likely to question the accuracy or validity of 
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the information about the consequences of inadequate fluid treatment control. In turn, this is 
likely to reduce the potency of the information to sustain behaviour change.  
 
Accumulated evidence suggests that a brief self-affirming activity, such as reflecting on the 
values we hold in high regard, can reduce resistance to threatening or dissonant health-risk 
information that conflicts with current beliefs and behaviour and increases the likelihood of 
behaviour change. Research examining the effectiveness of self-affirmation in the context of 
threatening health-risk information has largely focused on health behaviours affecting 
ostensibly “healthy” populations. These, include smoking cessation (Armitage, Harris, Hepton, 
& Napper, 2008), alcohol reduction (Armitage, Harris, & Arden, 2011), physical activity and 
healthy eating (Harris et al., 2014; D Jessop, Sparks, Buckland, Harris, & Churchill, 2014) and 
health screening attendance (van Koningsbruggen & Das, 2009). There is accumulating 
evidence that behavioural interventions based on self-affirmation theory can reduce resistance 
to unwelcome health risk information (Cohen & Sherman, 2014). Subsequently, self-affirmed 
participants typically find the health risk more threatening and personally relevant and report 
higher perceived self-efficacy and greater intentions towards the desired healthy behaviour 
(Epton & Harris, 2008; DC Jessop, Simmonds, & Sparks, 2009). 
 
Recently, we conducted the first study to explore the unique effects of self-affirmation in a 
patient group living with a long-term condition. Specifically, the study piloted a self-
affirmation theory based intervention aimed at improving phosphate binder medication 
adherence in patients receiving haemodialysis. A cluster randomised controlled trial 
demonstrated a significant effect of self-affirmation processes on improving patients’ 
phosphate treatment control over 12 months (Wileman et al., 2014). However, the trial also 
revealed some unexpected findings; self-affirmed and control patients did not significantly 
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differ in their responses to the health risk information or their intentions to control their 
phosphate. Therefore it was unclear what had led to the observed clinical effect. It is possible 
that the effects of self-affirmation might have arisen due to hidden mediators not assessed in 
the study such as stress reduction (Logel & Cohen, 2012), response efficacy (Epton & Harris, 
2008) or anticipated regret (van Koningsbruggen et al., 2014) and it is acknowledged that more 
research is needed to investigate this further. However, it was also considered that patients 
might not have ranked phosphate treatment high on their priorities compared with other, more 
demanding, aspects of treatment and this might have been reflected in the responses such as 
psychological threat (Karamanidou, Weinman, & Horne, 2013). Therefore, we chose to test the 
intervention in a new study, targeting a different treatment behaviour that is regarded as the 
most challenging for many patients receiving haemodialysis, restricting their fluid intake. 
Faced with a health-risk message about this particular aspect of treatment might arouse 
stronger cognitive and emotional responses and enable further examination of the effects of 
self-affirmation in this setting.  Further, it was of interest to explore the possibility that an 
effect of self-affirmation, if observed again, could potentially be strengthened by repeated 
exposure of the intervention alongside the repeated exposure of the health risk information.    
 
The present study therefore describes findings from a cluster randomised controlled trial which 
aimed to determine whether a self-affirmation theory based intervention altered patients’ 
perceptions of health risk information about the importance of fluid treatment control. It was 
predicted that, compared with a control group, patients receiving a brief self-affirmation 
activity would: (i) have a more positive evaluation of the fluid health risk information (i.e. 
report higher perceived message quality, higher perceived threat and less message derogation), 
ii) report greater intention and self-efficacy to improve fluid control, and (iii) have lower 
IDWG levels at follow-up.  
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Materials and methods 
 
Design The study was a two-armed pilot cluster randomised controlled trial comparing 
patients receiving information about the risks of inadequate fluid control to patients receiving 
the health-risk information following a brief self-affirmation activity. To reduce 
contamination, risk randomisation was by dialysis session (morning or afternoon, 
counterbalanced by day).  The first sessions in each centre was allocated on the basis of a 
randomly generated sequence, and subsequent sessions in each centre by counterbalancing.  
The randomised sequence was independently generated. Patients were followed up at 1, 4, 
12, 27, 40 and 52 weeks post intervention.  The primary behavioural outcome was adherence 
to prescribed fluid intake, indicated by IDWG. Patient self-reported adherence was also 
assessed. 
 
The self-affirmation intervention utilised in the current study was developed within studies 
assessing public health behaviour change and is relatively new in this clinical setting with just 
one prior study (Wileman et al., 2014). Therefore, there is limited evidence on which to 
estimate its potential effect and hence a pragmatic approach was adopted to estimate the 
required sample size following Medical Research Council guidelines. A target sample size of 
90 was chosen to allow estimation of the variances to a precision equivalent to the standard 
deviation, allowing a robust estimate of effect size to be determined. 
 
Patients and procedure  
Eligible patients from six UK dialysis units within three National Health Service Trusts, were 
identified by a nephrologist and invited to participate, provided they: a) had a three month 
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average IDWG of >2.0 kg, b) were ≥ 3 months from initiation of dialysis, c) were fluent in 
reading English, d) had not been hospitalised in the previous 3 months, and e) did not have 
other conditions likely to compromise short-term survival. Efforts were made to ensure that 
all eligible patients were invited to participate to minimize sampling bias.  
 
Ninety-one patients were recruited (Figure 1). Of all 662 patients present in the dialysis units, 
159 met the eligibility criteria and 91 provided informed consent. There were no differences 
(assessed by demographic variables and length of time receiving dialysis) between study 
participants and patients who chose not to participate. Two patients did not complete baseline 
questionnaires and were excluded from the analysis. Data are reported on patients who 
completed the intervention measures (n=89). 
 
Patients were provided with a Patient Information Sheet that had been approved by a National 
Health Service ethics committee, which specifically stated: This study aims to look at your 
views about fluid control information and your role in managing this. Patients completed 
questionnaires during their regular dialysis session.  The questionnaires were identical except 
the intervention-related material that preceded the fluid treatment health-risk information, 
where patients self-affirmed or completed a matched-control task. Patients were then 
presented with health-risk information, after which they completed measures designed to 
assess their responses to the information and their intention to control fluid intake. The self-
affirmation intervention was administered at baseline and a briefer version was repeated with 
each presentation of the health-risk information at 1, 3 and 6 months. The study was 
approved by the West of Scotland National Health Service ethics committee (ISRCTN: 
18080970). The clinical team who provided all patient care was blinded but the researcher, 
who enrolled patients to the trial and collected data, was unblinded.   
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Materials and measures 
 
Self-affirmation manipulation. Reed and Aspinwall’s (Reed & Aspinwall, 1998) 
manipulation required participants to recall their past acts of kindness. It consists of 10 
questions, for example ‘Have you ever been concerned with the happiness of another person 
yes or no? Patients were encouraged to elaborate on their recollection for yes responses. 
Control patients completed 10 matched control questions (also from Reed and Aspinwall) 
with no self-affirming properties such as ‘I think that the most aromatic trees in the world are 
pine trees. (Reed & Aspinwall, 1998). 
 
Health-risk information.  All patients received identical health-information about fluid 
control, with kind permission to reprint from The American Association of Kidney Patients 
(Hegel, 2002), which explained the possible consequences of high IDWG including muscles 
cramps, low blood pressure and the risk to their heart. Haemodialysis patients, not recruited 
for the present study, reviewed the questionnaires and health information prior to ethics 
review and confirmed that the information was appropriate and consistent with clinical 
advice.  
 
Health-risk information responses 
Immediately after reading the health information, patients were asked: “What did you think 
about the information you just read? Did you think it was . . .” to which they responded on 11 
items (e.g. not at all worrying – very worrying and not at all accurate – very accurate). Four 
of these items, adapted from (Witte, 2011)   were used to measure perceived threat namely 
frightening, concerning, worrying and distressing. Perceived message quality was measured 
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using five items, also adapted from (Witte, 2011), namely relevant, interesting, persuasive, 
helpful and accurate. Message derogation was measured using two items adapted from  (DC 
Jessop et al., 2009) namely overstated and exaggerated. 
 
Patients rated their intention and self-efficacy to control their fluid intake responding to three 
items for each construct e.g. Do you intend to keep within your recommended fluid intake 
during the next month? (I definitely do – I definitely do not) and How likely is it that you will 
manage to keep within your recommended fluid intake? (Not all likely – Very likely). Items 
were adapted from Armitage (Armitage et al., 2008).  All items were measured on 7-point (1 
to 7) scales. Self-reported responses were assessed after each presentation of the information. 
 
 
Interdialytic weight gain (IDWG) 
Adherence was assessed using IDWG (kg), which was collected at baseline, 1, 3, 6, 9 and 12 
months. Clinical data that might contribute to the variation in IDWG levels, including 
patients’ dry weight and dialysis adequacy (Kt/V) were extracted from dialysis unit 
databases.  
 
Self-reported measures 
Patients responded to a single item question to measure self-reported adherence “During the 
past month how often have you stuck to your maximum recommend fluid intake?” on a five 
point scale from “None of the time - All of the time”. Higher scores indicated higher 
adherence. Patients also completed the Patient Health Questionnaire(Kroenke, Spitzer, & 
Williams, 2003) to assess depressive symptoms and the Dialysis Thirst Inventory to measure 
perceived thirst (Bots et al., 2004). 
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Statistical methods   
Post intervention evaluations of the responses to health-risk information were assessed using 
mean difference and 95% confidence intervals.  Group differences were estimated using the 
intention-to-treat principle presented as unstandardised (i.e. original scale units) and as a 
standardised effects size (i.e. Cohen's d, standard deviation units). Tests for significant group 
differences were conducted using linear regression analyses, adjusting for baseline IDWG 
and cluster (unit, day and session).  
 
To explore the effect of group on the clinical outcome (IDWG) over time, a multi-level linear 
regression model was estimated, incorporating a random intercept. Dummy variables for 
time, treatment group and time by group interaction terms were included as covariates to 
allow treatment effects to vary across the post-intervention assessments, In addition, the 
models include covariates for randomised cluster and baseline clinical marker. All covariates 
were entered in one step.  
  
Results  
The mean age of the sample was 60.7 (SD=1.6) years. Women (n=24) represented 26.7% of 
the sample. The majority of the sample was of white European ethnicity (70.8%), median 
length of time receiving haemodialysis was 3.8 (IQR=4.9) years. Patients were receiving 
adequate dialysis treatment as assessed by (Kt/V) (M=1.4, SD=.24).  The mean IDWG 
assessed at baseline was 2.4 Kg (SD=.57) indicative of inadequate fluid control. Expressed as 
a percentage of dry-weight, the mean IDWG% was 3.2% (SD=.97). There were no significant 
differences between groups on any demographic and clinical factor, including baseline 
IDWG and comorbidity status, confirming successful randomisation (Table 1). 
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At twelve months, 60 patients were reassessed, representing an attrition rate of 33% (reasons 
for attrition are summarised in Figure 1). There were no demographic differences between 
completers and non-completers but there were some clinical and psychological differences. 
Non-completers had higher dialysis temperature (p<.01) and reported being more careful with 
their salt intake (p=.01).  
 
All patients randomised to the intervention group (n=49) completed the self-affirmation task, 
with 71 % (n=35) responding Yes to at least 8 of the 10 kindness items. Twenty of the 49 
patients did not elaborate following a positive (i.e. yes) response. Whether patients elaborated 
or not was not a significant predictor in the IDWG model below (p=.86).   
 
Post intervention measures  
Evaluation of the health-risk information   
Contrary to predictions, there were no significant differences between self-affirmed and non-
affirmed patients on post intervention ratings of perceived threat, perceived message quality, 
message derogation, and intention. Unadjusted mean ratings of perceived threat were higher 
(albeit non-significant) in affirmed compared to control patients (Cohen’s d=.21, Table 2) but 
this effect was lost when adjusted for baseline IDWG and cluster. Responses assessed at 1, 3 
and 6 months were also assessed and no group differences were observed. 
 
IDWG (Kg) change over 12 months 
A multilevel model, adjusting for baseline IDWG and cluster, was undertaken to assess 
whether group status (self-affirmation vs. controls) predicted IDWG reduction over 12 
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months. A significant group by time interaction was observed (Χ2=26.2, p=.02, Fig. 2). The 
considerable reduction in IDWG from baseline to six months for self-affirmed patients 
appears to have contributed to this overall effect with a mean within-group IDWG reduction 
of .34 Kg (SD=.89), p=.02, Cohen’s d=.55. For control patients over the same period, there 
was virtually no reduction in IDWG (M=.01Kg, SD=.67, p=.78, d=.06). The model adjusted 
mean difference (Table 3) between groups at six months was significant and with a medium 
effect size (z= -.1.9, p= 0.04, d=.40). After a further six months, both groups observe a slight 
increase in mean IDWG levels. This is discussed below. 
 
Self-reported fluid adherence 
Although not a primary outcome, it is desirable to obtain patient self-reported adherence 
measures in addition to a clinical outcome. At baseline, there was no differences in self-
reported adherence to keeping within recommended fluid limits between self-affirmed        
(M: 3.4, SD=.81) and control patients (M: 3.4, SD=1.1), (t (84)=.07, p=.95, Cohen’s d=.0). 
At one month follow up, self-affirmed patients’ self-reported adherence scores increased 
whereas controls remained the same. The unadjusted mean difference (from baseline) 
between groups was significant (MD=-.34, t(68)=-2.0, p=<.05, Cohen’s d=.49) though this 
effect was not maintained in adjusted analysis (see Table 3). At six months, self-affirmed 
patients’ self-reported adherence remained higher than controls although the unadjusted 
difference from baseline was non-significant (MD=-28, t(52)=-1.06, p=.29, Cohen’s d=.39). 
 
 
Discussion  
Inadequate fluid control as measured by IDWG is associated with poor outcomes in HD 
patients, thus interventions to help patients adhere to this behaviour are needed. This is just 
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the second study to evaluate the efficacy of a behavioural intervention based on self-
affirmation theory among people with ESKD receiving haemodialysis. To our knowledge, it 
is one of only two studies to assess the unique effects of self-affirmation in a clinical setting 
such as ESKF (Wileman et al., 2014). This study aimed to determine whether a self-
affirmation theory based intervention altered patients’ perceptions of the health risk 
information and subsequent behaviour indicated by an improvement in fluid control 
(reduction in IDWG).  An effect of self-affirmation on behaviour, indicated by a greater 
reduction in self-affirmed patients’ improved IDWG levels, compared with controls, was 
established. Further, patients who self-affirmed, but not control patients, significantly 
increased their self-reported adherence levels at follow-up. However, support for some of the 
predictions derived from self-affirmation theory was not found. Specifically both the 
intervention and control groups held similar evaluations of the health risk information 
(regarding the need for adequate fluid control) and had similar intentions about controlling 
their fluid intake. These surprising null findings support those observed in our past study 
(Wileman, et al 2014). Accordingly, there is still a need to establish potential mediators of the 
observed effects. 
 
Evaluation of the health risk information  
Self affirmed patients did not differ significantly from controls in their responses to the health 
risk information. In some cases there was virtually no difference in the group means. Most 
patients reported high intentions to control fluid suggesting that they were already motivated 
to management their treatment and that there was limited scope to change. One exception to 
this lack of variation was patients’ reported perceived threat at baseline though the difference 
remained non-significant. Self-affirmed patients rated the health message to be more 
threatening than controls with small effect sizes observed (d=.21), consistent with previous 
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research (Armitage et al., 2011; Good & Abraham, 2011). However the effect was lost when 
adjusted for clinical factors.  
 
These results reflect the findings in the previous study which evaluated self-affirmation in a 
different treatment regimen, adherence to phosphate binding medication (Wileman et al., 
2014). It was considered whether the lack of group differences in responses to health-risk 
information in the phosphate study was possibly due to the fact that patients might not rank 
phosphate treatment high on their priorities compared with other aspects of treatment and this 
might have been reflected in the responses. It was speculated that adherence to fluid control, 
a treatment that is particularly salient to patients (Karamanidou et al., 2013)  might stimulate 
stronger feelings and that this might be evident in psychological responses to threat. 
However, the present study’s findings suggest that this is not the case. It is likely therefore 
that the effects of affirmation have arisen due to hidden mediators not assessed and more 
research is needed to identify these measures further. One public health study that also 
reported no group effect on intention but observed an effect on behaviour change, established 
that Response Efficacy, the belief that undertaking the required behaviour will result in 
desirable outcomes and therefore remove the imminent threat, mediated the effects of self-
affirmation(Epton & Harris, 2008).  Van Koningsbruggen demonstrated that anticipated 
regret mediated the effects of self-affirmation on intentions (van Koningsbruggen et al., 
2014). Stress reduction or mood enhancement is also a likely consideration which should be 
assessed in future studies (Cohen & Sherman, 2014). 
 
It is also possible that the questionnaire items, developed in studies evaluating public health 
behaviour change, were not sufficiently effective in capturing these patients’ feelings and 
thoughts about their treatment. The burden of treatment for patients living with ESKD is 
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immense and perhaps trying to isolate potentially complex perceptions with relatively 
straightforward questionnaire items regarding health risk information is not feasible. Instead, 
consideration needs to be given to the means by which such psychological responses could be 
assessed. Future work also needs to consider the actual means by which patients self-affirm. 
It is important to determine whether alternative self-affirmation manipulations lead to similar 
treatment effects to those observed here and whether they impact hypothesised mediators.  
 
Assessing behaviour change 
A significant adjusted mean IDWG reduction was observed over the study duration. On 
average patients who self affirmed managed to lower their IDWG by approximately one third 
of a kilogram, reducing their average IDWG of 2.5kg down to 2.1kg in a 7-day average 
assessment at six months. Like the previous phosphate study (Wileman et al., 2014), patients 
were shown repeated health-risk information on four occasions up to six months. After this 
time, only clinical data was collected. In the previous study the observed effects on serum 
phosphate were present over 12 months but in the current study, this does not appear to be the 
case. It is possible that in the case of fluid control behaviour, continued presentation of the 
health-risk information would perhaps increase the effect over time. 
 
Assessing self-reported adherence complements the clinical proxy measure of adherence 
(IDWG). Self-affirmed patients reported a significant increase in adherence one month after 
the baseline intervention compared with controls and maintained similar levels over six 
months. Whilst these data do not necessarily provide any further insight as to the mechanisms 
that led to self-affirmed patients’ mean reduction in IDWG post intervention, the fact that 
patients told us that they had managed to improve their fluid intake control is reassuring 
validation of the clinical outcome. 
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Strengths and limitations  
The study has a relatively small sample size but benefitted from recruiting a diverse and 
realistic participant group. It is also acknowledged that the study sample had varying levels of 
IDWG and not all patients would have been categorised as high risk of poor treatment 
control. Future studies would benefit from ensuring that patients whose clinical measures 
indicate clear non-adherence and risk of consequences, are eligible to take part. The study 
experienced quite high attrition levels (33% at 12 months) but the reason for patients leaving 
the trial was for clinical reasons, transplantation being the commonest (14 patients (16%)).  
While all efforts were made to take each patient through the same process it is not possible to 
manage all potential confounding variables in a clinical environment and therefore the study 
cannot have achieved the control possible with laboratory based studies. However, ultimately 
such interventions need to be translatable into a clinical context and therefore this limitation 
can also be perceived as a strength, since this intervention approach has potential application 
within routine clinical practice.  We did not control for residual kidney function since this 
was not routinely measured in most of the centres. However our selection of patients with 
baseline IDWG > 2kg would be likely to have excluded most patients with significant 
residual renal function. Furthermore any loss of residual renal function during the course of 
the study will have tended to increase IDWG rather than reduce it. The researcher was not 
blinded to treatment condition so the potential for bias exists. However this is a relatively 
small risk given the objective nature of the outcome variable (IDWG), the blinding of the 
clinical team providing all the patient care, and the absence of significant changes in self-
report measures – potentially more vulnerable to researcher bias.  Finally, this study gains 
from having a clinical proxy measure of behaviour change as well as patient self-report.  
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Summary 
In summary, this investigation confirmed similar findings established in our previous study in 
respect of phosphate control (Wileman et al., 2014). A behaviour change intervention based 
on self-affirmation theory was associated with improved treatment control but the mechanism 
by which this apparent behaviour change occurred is uncertain.  
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Figures and Tables 
 
Fig 1. Patient recruitment flow chart 
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Table 1: Patient characteristics by group 
Control Intervention
Mean (SD) Mean (SD)
Baseline measures Scale  (n=40 ) (n=49 )
Women [n (%)] 10 [42] 14 [58]
Men [n (%)] 30 [46] 35 [54]
Age (years) 58.2[16.0] 62.8 [14.9]
Dialysis vintage (years) (Median [IQR]) 2.9 [ 1.4 - 5.6] 2.6 [ 1.2 - 5.6]
Patients' self-reported adherence 1-5 3.4 [1.1] 3.4 [ .81]
Perceived importance of fluid treatment control 1-7 6.2 [ 1.2] 5.9 [ 1.4]
Perceived thirst 0-35 19.5 [7.4] 20.8 [7.5]
Depressive symptoms (PHQ2)  0-6 1.7 [ 2.0] 2.3 [2.2]
Bio measures (three month average)
Dry weight (Kg) 79.6 [22.0] 77.8 [16.1]
IDWG  2.45 [ .54] 2.40 [.50]
IDWG as percentage of dry weight (Kg) 3.2 [.92] 3.2 [.77]
Kt/V  1.46 [.26] 1.41 [.23]
Dialysate sodium mmol/l 138 [1.5] 138 [1.5]
Dialysis temperature (°C) 36.1 [.72] 36.1 [.72]
Serum sodium mmol/l 138[2.8] 138 [2.4]
PHQ2 : Patient Health Questionnaire  
Data reported are means (SDs) unless otherwise stated. IQR: Interquartile Range. 
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Table 2 Group differences in health risk information evaluation (at baseline) 
 
  
All Control Intervention
Post intervention measures Range α   (n=40) (n=49) p effect size t p>|t| effect size
Perceived threat 4 - 28 .91 18.7 (7.3) 17.9 (7.0) 19.4 (7.5) -1.5 (-4.6 to 1.6) .34 .21 .44 (-2.8 to 3.7) .27 .79 .10
Perceived message quality 5 - 35 .70 30.2 (4.7) 30.5 (3.7) 30.0 (5.4) .54 (-1.4 to 2.5) .59 .15 -1.3 (-3.4 to .71) -1.3 .20 .24
Message derogation 2 - 14 r=.57** 5.0 (3.6) 5.3 (3.6) 4.7 (3.6) .61 (-.91 to 2.1) .43 .17 -.20 (-1.8 to 1.4) -.24 .81 .10
Intention to control fluid 3 - 21 .82 16.3 (4.0) 16.2 (4.3) 16.4 (3.8) -.23 (-1.9 to 1.5) .79 .10 -.27 (-2.0 to 1.5) -.31 .76 .10
Intention to control salt 4 - 21 .75 16.3 (4.4) 16.7 (4.5) 16.1 (4.3) .59 (-1.3 to 2.4) .53 .13 -.94 (-2.9 to 1.0) -.95 .34 .18
Self-efficacy in controlling fluid 2 - 14 r=.48** 7.9 (3.4) 8.2 (3.5) 7.7 (3.3) .46 (-.99 to 1.9) .53 .13 -.45 (-2.0 to 1.1) -.59 .56 .11
Self-efficacy in controlling salt 3 - 21 .63 14.5 (4.8) 14.9 (4.8) 14.2 (4.9) .75 (-1.3 to 2.8) .47 .15 -.70 (-2.8 to 1.4) -.65 .51 .12
Adjusted mean difference [CI]Mean difference [CI]
d : Cohen's d . Adj Means: adjusted for baseline IDWG, experimental group and cluster (trust, unit, day and session).
α= Cronbach's alpha. Pearson's r  for two item scales. ** p <.001. Means [SD]. Unadjusted means [CI: 95% Confidence Intervals]. The mean effect size reported is the standardised mean difference 
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Table 3 Group differences in interdialytic weight gain (IDWG) and self-reported adherence (MARS) 
 
All Control Intervention Mean difference [CI]
    (n=40) (n=49) p
effect 
size
 z p>|z|
effect 
size
Interdialytic weight-gain (IDWG) Kg Kg Kg
Baseline  2.4 (.57)  2.3 (.55) 2.5 (.57) -.14 (-.38 to .09) .23 .26 .04 (-.21 to .28) .30 .77 .06
6 month follow-up (n=72) 2.2 (.90) 2.3 (.77) 2.1 (.99) .17 (-.26 to .59) .44 .22 -.28 (-.55 to -.01) -2.1 .04 .43
Mean reduction at 6 months .19 (.81) -.01 (.67) -.34 (.89) .33 (-.04 to .72) .08 .50 -.32 (-.64 to .01) -1.9 .05 .40
12 month follow-up (n=60) 2.4 (.73)  2.4 (.65) 2.4 (.78) .03 (-.36 to .41) .89 .04 -.17 (-.46 to .13) -1.1 .27 .23
Mean reduction at 12 months .02 (.74) .17 (.62) -.07 (.80) .25 (-.14 to .63) .21 .40 -.20 ( -.55 to .15) -.1.4 .25 .24
 p
effect 
size
t p>|z|
effect 
size
Baseline  3.4 (.94) 3.4 (1.1) 3.4 (.81) .01 (-.40 to .42) .95 .01 -.06 (-.50 to .38) -0.23 .78 .05
1 month follow-up  (n=68) 3.5 (.91) 3.4 (.99) 3.6 (.82) -.24 (-.67 to .19) .27 .24 -.03 (-.51 to .45) -0.13 .90 .02
Mean difference at 1 month .07 (.78) -.13 (.76) .24 (.76) -.37 (-.74 to -.00) <.05 .49 .18 (-.24 to .61) .86 .40 .16
6 month follow-up 3.4 (.92) 3.3 (.88) 3.5 (.97) -.12 (-.64 to .40) .65 .13 -.05 (-.56 to .45) -0.2 .82 .04
Mean difference at 6 months .02 (.94) -.17 (.72) .10 (1.1) -.28 (-.80 to .25) .30 .39 .04 (-.50 to .57) .16 .88 .03
Self-reported adherence [MARS scale: 1-5 where high scores represent higher adherence)  
d: Cohen's d. Adjusted mean difference for baseline IDWG, experimental group and cluster (trust, schedule and session). 
 
Adjusted mean difference [CI]
Means [SD]. Unadjusted means [CI: 95% Confidence Intervals]. Mean effect sizes: the effect size reported is the standardised mean difference
Self-reported adherence (Scores:1-5)
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Fig 2 Model estimated adjusted interdialytic weight gain 
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